Mulas O, Abruzzese E, Luciano L, Iurlo A, et al. The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib. Ann Hematol 2023 Nov 28. doi: 10.1007/s00277-023-05556.
PMID: 38012435